107 related articles for article (PubMed ID: 8375124)
1. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
Wang JP; Unadkat JD; al-Habet SM; O'Sullivan TA; Williams-Warren J; Smith AL; Ramsey B
Clin Pharmacol Ther; 1993 Sep; 54(3):293-302. PubMed ID: 8375124
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.
de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL
Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222
[TBL] [Abstract][Full Text] [Related]
3. An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.
Roberts GW; Nation RL; Jarvinen AO; Martin AJ
Br J Clin Pharmacol; 1993 Oct; 36(4):372-5. PubMed ID: 12959319
[TBL] [Abstract][Full Text] [Related]
4. Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis.
Jacobs RF; Trang JM; Kearns GL; Warren RH; Brown AL; Underwood FL; Kluza RB
J Pediatr; 1985 Jun; 106(6):1001-7. PubMed ID: 3998937
[TBL] [Abstract][Full Text] [Related]
5. Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.
Hedman A; Adan-Abdi Y; Alvan G; Strandvik B; Arvidsson A
Clin Pharmacokinet; 1988 Jul; 15(1):57-65. PubMed ID: 3042246
[TBL] [Abstract][Full Text] [Related]
6. Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.
Hedman A; Alván G; Strandvik B; Arvidsson A
Clin Pharmacokinet; 1990 Feb; 18(2):168-75. PubMed ID: 2180614
[TBL] [Abstract][Full Text] [Related]
7. The tubular excretion of benzylpenicillin in patients with cystic fibrosis.
Bins JW; Mattie H
Br J Clin Pharmacol; 1989 Mar; 27(3):291-4. PubMed ID: 2719893
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis].
de Meirleire F; Fauchere JL; Simon G
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial chemotherapy in patients with cystic fibrosis.
Guggenbichler JP; Schneeberger J
Infection; 1987; 15(5):397-402. PubMed ID: 3692614
[TBL] [Abstract][Full Text] [Related]
10. Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.
Hutabarat RM; Unadkat JD; Sahajwalla C; McNamara S; Ramsey B; Smith AL
Clin Pharmacol Ther; 1991 Apr; 49(4):402-9. PubMed ID: 2015729
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the effects of oral probenecid on the pharmacokinetics of intravenous ticarcillin in patients with cystic fibrosis.
Corvaia L; Li SC; Ioannides-Demos LL; Bowes G; Spicer WJ; Spelman DW; Tong N; McLean AJ
J Antimicrob Chemother; 1992 Dec; 30(6):875-8. PubMed ID: 1289366
[No Abstract] [Full Text] [Related]
12. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
Zobell JT; Stockmann C; Young DC; Cash J; McDowell BJ; Korgenski K; Sherwin CM; Spigarelli M; Chatfield BA; Ampofo K
Clin Ther; 2011 Nov; 33(11):1844-50. PubMed ID: 22018680
[TBL] [Abstract][Full Text] [Related]
13. Simple sampling strategy for measuring inulin renal clearance.
Horio M; Imai E; Yasuda Y; Hishida A; Matsuo S;
Clin Exp Nephrol; 2009 Feb; 13(1):50-4. PubMed ID: 18827963
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of ticarcillin in patients with abnormal renal function.
Parry MF; Neu HC
J Infect Dis; 1976 Jan; 133(1):46-9. PubMed ID: 1107435
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
16. Renal handling of the monobactam azthreonam in healthy subjects.
Swabb EA; Sugerman AA; Frantz M; Platt TB; Stern M
Clin Pharmacol Ther; 1983 May; 33(5):609-14. PubMed ID: 6682362
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
[TBL] [Abstract][Full Text] [Related]
18. Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosis.
O'Sullivan TA; Wang JP; Unadkat JD; al-Habet SM; Trager WF; Smith AL; McNamara S; Aitken ML
Clin Pharmacol Ther; 1993 Sep; 54(3):323-8. PubMed ID: 8375128
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular secretion of meperidine by the fetal lamb.
Szeto HH; Clapp JF; Larrow RW; Inturrisi CE; Mann LI
J Pharmacol Exp Ther; 1980 May; 213(2):346-9. PubMed ID: 7365693
[TBL] [Abstract][Full Text] [Related]
20. Urinary pH and urine flow independent renal clearance of methotrexate in dogs.
Lui CY; Lee MG; Chiou WL
J Pharmacokinet Biopharm; 1985 Apr; 13(2):159-71. PubMed ID: 4057055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
